Company
United StatesNorthern Indiana Cancer Research Consortium IRB, South Bend, IN – FDA Inspections
Inspection records and compliance data for Northern Indiana Cancer Research Consortium IRB in South Bend, Indiana. 2 FDA inspections on record (1 OAI), last inspected November 05, 2013.
Company Profile
This profile covers Northern Indiana Cancer Research Consortium IRB based in South Bend, Indiana, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 1
- VAI
- 0
- NAI
- 1
- Form 483s
- 0
- Warning letters
- 0
First inspected February 21, 2012. Last inspected November 5, 2013.
Most cited issue areas
- Initial and continuing reviews1 inspection
- Minutes of IRB meetings1 inspection
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| November 5, 2013 | NAI | Human Drugs · Bioresearch Monitoring | 854295 |
| February 21, 2012 | OAI | Human Drugs · Bioresearch Monitoring | 771895 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Northern Indiana Cancer Research Consortium IRB
FEI Number
3009194999
Address
100 Navarre Pl, South Bend, Indiana 46601, United States
Country
United States
ID: c4163fa0-dc6c-4fa8-b7a0-2df7d8b53b45